Sugi Predict

Sugi Predict / Compounds / SCHEMBL6701320

SCHEMBL6701320

SCHEMBL6701320

Cc1ccc(C)n1-c1cccc(-c2ccc(-c3ccc(C=O)cc3)cc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ALDH1A1 P00352 6/20 0.35
▸ MAPT P10636 3/20 0.35
▸ CYP2A6 P11509 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ BCL2 P10415 1/20 0.34
▸ BAX Q07812 1/20 0.34
▸ BCL2L1 Q07817 1/20 0.34
▸ DRD1 P21728 2/20 0.33
▸ COMT P21964 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CYP11B1 P15538 1/20 0.31
▸ AR P10275 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618761 0.98 KDM4E (0.38) KDM4ELMNAALDH1A1MAPTCYP2A6
SCHEMBL17721461 0.81 CYP2A6 (0.40) KDM4ELMNAALDH1A1MAPTCYP2A6
SCHEMBL2969912 0.79 RAB9A (0.54) KDM4ELMNAALDH1A1MAPTCOMT
SCHEMBL6696955 0.78 RAB9A (0.42) KDM4ELMNAALDH1A1MAPTPOLB
SCHEMBL29042272 0.77 MEN1 (0.52) KDM4ELMNAALDH1A1MAPTCYP2A6
SCHEMBL6621303 0.77 KDM4E (0.50) KDM4EALDH1A1MAPTPOLBHPGD
SCHEMBL9848050 0.76 MAPT (0.47) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL6700787 0.75 CYP2A6 (0.53) ALDH1A1CYP2A6CYP11B1
SCHEMBL6620028 0.73 KLKB1 (0.54) LMNAPOLBMEN1RAB9AKMT2A
SCHEMBL6618175 0.72 NOS1 (0.36) KDM4ELMNAALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142924-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors PFIZER INC 2004-07-22 — — US disclosed
EP-0946512-B1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER (US) 2003-10-08 — — EP disclosed
US-20020103227-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors LOWE JOHN A (US) 2002-08-01 — — US disclosed
US-20020032191-A1 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors LOWE JOHN A (US) 2002-03-14 — — US disclosed
US-6235750-B1 NITRIC OXIDE SYNTHASE INHIBITOR PFIZER INC 2001-05-22 — — US disclosed
EP-0946512-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1999-10-06 — — EP disclosed
WO-1998024766-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1998-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032191-A1 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 KDM4E 1439/4885LMNA 2947/4885ALDH1A1 438/4885
US-20040142924-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 KDM4E 1439/4885LMNA 2947/4885ALDH1A1 438/4885
US-20020103227-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 KDM4E 1439/4885LMNA 2947/4885ALDH1A1 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.